Johnson & Johnson buy Royal Bank of Canada
Summary
This prediction is currently active. With a performance of 7.33%, the BUY prediction by Royal_Bank_of_Canada for Johnson & Johnson is trending in the right direction. Dividends of €1.11 are taken into consideration when calculating the performance. This prediction currently runs until 22.05.25. The prediction end date can be changed by Royal_Bank_of_Canada at any time. Royal_Bank_of_Canada has 50% into this predictionJohnson Johnson is a multinational company that focuses on the development, manufacturing, and marketing of a wide range of consumer health products, medical devices, and pharmaceuticals. The company was founded in 1886 and is headquartered in New Jersey, USA. It operates in more than 60 countries and has a diverse portfolio of popular brands including Band-Aid, Tylenol, and Neutrogena. As of 2021, Johnson Johnson has a market capitalization of over $435 billion and is listed on the New York Stock Exchange under the symbol JNJ.
Performance without dividends (%)
Name | 1w | 1m |
---|---|---|
Johnson & Johnson | 2.305% | 2.305% |
iShares Core DAX® | 1.560% | 4.721% |
iShares Nasdaq 100 | 0.517% | 1.171% |
iShares Nikkei 225® | 1.730% | 6.073% |
iShares S&P 500 | 1.482% | 1.218% |
Comments by Royal_Bank_of_Canada for this prediction
In the thread Johnson & Johnson diskutieren